Delivery Order SPE2DB20D3103-SPE2DB23FN4L6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of norepinephrine 8 mg/250 ml-D5W 250ml. The contract, valued at $2,796.06, is a firm fixed-price delivery order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.35, is for the delivery of Norepinephrine 8 mg/250 mL-D5W 250 mL. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,130.04 firm fixed-price delivery order is for the supply of 4560360573 Norepinephrine 8 mg/250 ml-D5W 250 ml, a critical medication used in military and veterans' healthcare programs. The contract has a completion date of March 24, 2023 and does not include any set-aside requirements, indicating open competition....
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $1,591.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for norepinephrine 4ML 10s, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 30, 2023. The $1,530.38 firm fixed-price delivery order is for the supply of 4561390219 NOREPINEPHRINE 4 MG/250 ML-D5W 250ML, a critical medication used in healthcare settings. The contract has a completion date of July 3, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Norepinephrine 4 mg/4 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,578.89, and has a completion date of May 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, worth up to...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,776.84, is for the delivery of 4564394146 norepinephrine 4ML medication. The contract has a completion date of April 25, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,323.74 on August 8, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W 250 ml units. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a non-set-aside competitive award from the Defense Logistics Agency's Medical Supply Chain, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Norepinephrine is a critical vasopressor medication used...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB23FVQ90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560896338 - Norepinephrine 8 mg/250 ml-D5W 250 ml, a pharmaceutical product. The contract has a ceiling value of $1,624.18 and is a Firm Fixed Price Delivery Order type, with a period of performance through May 11, 2023. This award is not associated with a set-aside designation,...
- This federal contract award is for the delivery of 4 mg/4 ml vials of the pharmaceutical drug norepinephrine, with a ceiling value of $2,008.70. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN4L6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,714.94 firm fixed-price delivery order is for the supply of 4560983330 - Norepinephrine 4 mg/250 ml-D5W 250 ml, with a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There was no set-aside designation for this specific contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/18/23 |